PAIN
Volume 141, Issue 1 , Pages 4-5, January 2009

Improving early clinical drug development for neuropathic pain by improving patient selection

Karolinska Institute, Department of CLINTEC, Unit for Anesthesia, SE-141 86 Stockholm, and AstraZeneca R&D, SE-151 85 Södertälje, Sweden

Received 10 November 2008; accepted 10 November 2008. published online 12 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(08)00701-X

doi:10.1016/j.pain.2008.11.003

Refers to article:

  • Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies , 17 November 2008

    T.W. Ho, M. Backonja, J. Ma, H. Leibensperger, S. Froman, M. Polydefkis
    PAIN January 2009 (Vol. 141, Issue 1, Pages 19-24)

PAIN
Volume 141, Issue 1 , Pages 4-5, January 2009

Article Tools